Alpha Holdings

Alpha Holdings

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

South Korea, Pangyo

About

The main office of this Corporate Investor is situated in Pangyo. The fund is located in South Korea, Asia.

OncoSec Medical is among the most popular portfolio start-up of the fund. The country of its establishment and the country of its most frequent investments doesn't coincide - United States. Also, a start-up has to be aged 6-10 years to expect investment from this fund. Among the most popular investment industries for the fund are Life Science, Biotechnology. However, the fund’s focus is not limited to this, since there is 1 more area of investment.

The fund usually invests by oneself. Aside from Alpha Holdings, start-ups are often funded by National Institutes of Health.

The most exits for the fund occurred in 2010. The fund generally invests in less than 2 deals every year. Typical investments for this fund are deals in the range of 10 - 50 millions dollars. In 2018, the fund's activity was at its peak.

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: alpha.com; User name format in descending order of probability: first last, first_initial last, first last_initial, last, first

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing in Previous
Rounds

National Institutes of Health

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: